Predicting cognitive impairment in Parkinson's disease using neurophysiology and biochemical parameters as biomarkers
Parkinson’s disease (PD) is a common neurodegenerative condition with multiple associated non-motor symptoms. Of these, dementia is a frequent debilitating complication of the disorder, with significant morbidity and mortality. Some forms of mild cognitive impairment in PD (PD-MCI) may represent a p...
Main Author: | Yarnall, Alison Jane |
---|---|
Published: |
University of Newcastle upon Tyne
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603410 |
Similar Items
-
A neurophysiologically plausible model for the origin of beta oscillations in Parkinson's Disease
by: Pavlides, Alex P.
Published: (2013) -
Investigating reach and grasp in Parkinson's disease cognitive impairment
by: Cosgrove, Jeremy
Published: (2016) -
DNA methylation as a biomarker for age-related cognitive impairment
by: Barrett, Laura Michelle
Published: (2015) -
Is dynamic cerebral autoregulation impaired in idiopathic Parkinson's disease?
by: Haunton, Victoria Joanna
Published: (2014) -
A Clinical and Biochemical Study of L-Dopa in the Treatment of Parkinson's Disease
by: Morris, J. G. L.
Published: (1976)